ERN1 and atherosclerosis: Interestingly, inhibition of IRE1 delays the progression of atherosclerosis in the apolipoprotein E-deficient mice and intraperitoneal chronic administration of STF-083010, an inhibitor of IRE1α reduced aorta plaque lesions by 35% (136).